Workflow
上海莱士(002252) - 2015 Q2 - 季度业绩
Shanghai RAASShanghai RAAS(SZ:002252)2015-07-29 16:00

Financial Performance - Total operating revenue for the first half of 2015 reached ¥816,590,564.90, representing a 50.63% increase compared to the same period last year[4] - Net profit attributable to shareholders was ¥833,350,770.71, marking a significant growth of 380.07% year-on-year[4] - The substantial increase in revenue and net profit was primarily due to the consolidation of the financial results of Tonglu Biological Pharmaceutical Co., Ltd. since December 2014[5] - Basic earnings per share rose to ¥0.608, a 297.39% increase compared to ¥0.153 in the previous year[4] - The weighted average return on net assets improved to 9.01%, an increase of 2.60 percentage points from 6.41%[4] - The company did not experience any discrepancies between the actual results and the previously announced profit forecast, which estimated a net profit growth of 365% to 385%[7] - The increase in performance was also supported by gains from fair value changes in securities investments[6] Assets and Equity - The company's total assets at the end of the reporting period were ¥10,788,909,267.41, up 15.03% from the beginning of the period[4] - The equity attributable to shareholders increased to ¥9,968,434,591.07, reflecting a growth of 15.78%[4] - The company's share capital increased slightly by 0.94% to ¥1,378,129,917.00[4]